Skip to main content

Table 1 List of included studies utilised in indirect comparison of gemcitabine based combination chemotherapy

From: Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison

Comparison

Trial

Group (number randomised)

Gemcitabine versus gemcitabine plus capecitabine

Cunningham 2005 (interim analyses) [12]

Gemcitabine (n = 266)

Gemcitabine combination (n = 267)

 

Hermann 2005 [13, 14] (analyses based on data from abstract published in 2005, plus extra data provided by trialist)

Gemcitabine (n = 159)

Gemcitabine combination (n = 160)

 

Scheithauer 2003 [15]

Gemcitabine (n = 42)

Gemcitabine combination (n = 41)

Gemcitabine versus gemcitabine plus 5FU

Berlin 2002 [8]

Gemcitabine (n = 162)

Gemcitabine combination (n = 160)

 

Di Costanzo 2005 [10]

Gemcitabine (n = 48)

Gemcitabine combination (n = 43)

 

Reiss 2005 [9]

Gemcitabine (n = 236)

Gemcitabine combination (n = 230)

Gemcitabine versus gemcitabine plus platinum compound

Heinemann 2006 [16]

Gemcitabine (n = 99)

Gemcitabine combination (n = 96)

 

Louvet 2005 [17]

Gemcitabine (n = 163)

Gemcitabine combination (n = 163)

 

Poplin 2006 [18]

Gemcitabine (n = 280)

Gemcitabine combination (n = 276)

Gemcitabine versus gemcitabine plus irinotecan

Rocha Lima 2004 [19]

Gemcitabine (n = 180)

Gemcitabine combination (n = 180)

 

Stathopoulos 2005 [20, 21] (analyses based on data from abstract published in 2005, plus extra data provided by trialist)

Gemcitabine (n = 69)

Gemcitabine combination (n = 57)